MFGI 62.00   -  Updated: 09-26-2017 $MFGI Last Trade:

Diving Deep into Conversation Intelligence There's a lot to unpack when three software titans hog the spotlight, and that's exactly what's happening in the world of conversation intelligence this year. It's like we've hit the jackpot with Gong, Agentforce Sales, and Avoma carving out their turf as the 2026 Champions, according to the venerable Info-Tech Research Group....

A Novel Leap in Production Capacity EMCO Industries just put a solid foot on the accelerator with their brand-new, shiny, fully automated plant over in Claremore, Oklahoma. If you're glancing at heavy-duty trailer springs, you can't ignore the fact that this is a multimillion-dollar investment. Heck, this monstrous 30,000-square-foot facility more than doubles what EMCO...

HelloNation's Bold Step into Real Estate Networking October 8th to the 11th is shaping up to be a pivotal few days in Wilmington, North Carolina. Here’s the scoop: HelloNation, known for its innovative 'edvertising' model, is joining the bustling crowd at the 2026 NC REALTORS® Convention. This isn’t just any get-together—it's the grandest annual jamboree for real...

OCI Dodges a Bullet in Amsterdam Court Stepping into the courtroom drama, OCI N.V. just took home a win as the Amsterdam Court of Appeal's Enterprise Chamber gave them a clean bill of health, kicking out the inquiry request from VEB and a bunch of other shareholders. The judges weren't convinced there was anything fishy going on, so they tossed the inquiry petition and...

A Year Marked by Weather's Unpredictable Dance Nobody said making wine was a walk in the park, and the folks at Ornellaia know better than most how to roll with whatever nature throws their way. The 2026 harvest story is as much about unlocking the secrets of the soil as it is about navigating the quirks of the weather. Situated in Bolgheri, Italy, this year's vintage...

A New Breath of Fresh Air for Dental Care Dental visits—a tedious, costly affair we've all dreaded. So, when Wally rolls out an overhaul in this stale landscape, it's worth taking notice. With $25 million in their pockets from Series A funding led by Maveron, Wally's swaggering in with a plan to flip the script on dental care across the nation. Redefining the Dental...

Merit Financial's Growth Trajectory Takes a Leap You watch the movers and shakers in this game long enough, and you start to see patterns. Merit Financial Advisors is one of those juggernauts you'd better keep an eye on. These folks just scooped up Moldenhauer & Associates—a firm that's been a staple in Orchard Park, New York—for a cool $1.1 billion worth of client...

Navigating the Waters of Global Nutrition Bet you never thought a vitamin program could spearhead the front lines of healthcare, huh? Vitamin Angels are grinding away under the radar, shifting the landscape for maternal and child nutrition. At the heart of it all is their vision to make UNIMMAP multiple micronutrient supplementation (MMS) a staple in the global playbook....

What’s Behind Door Number One: CarBravo Certification When you walk onto a car lot these days, it's a mixed bag: shiny badges boasting certifications or basic used car signage. For anyone who's spent time around cars, two types stick out—there’s your CarBravo-certified vehicles and your good ol' used cars. Now, Marissa McCoy and Jill Maniaci from Heidebreicht...

Shielding Customers From Data Center Costs Let's get right into the thick of it: Duke Energy's latest move is a strategic one, shrouded in industry terms but with a real impact on regular folks' wallets. The company's agreement with heavyweights like Amazon, Google, and Meta aims to protect existing customers in North Carolina from getting hit with the costs of powering...

Overview of Taitron's Recent Developments Taitron Components Incorporated (NASDAQ: TAIT) recently made headlines by announcing its voluntary delisting from The Nasdaq Stock Market. The company's decision came as it recognized that the cost of maintaining its Nasdaq listing outweighed the benefits for its shareholders. Reasons Behind the Delisting The board concluded that...

Merck's Groundbreaking Two-Drug Regimen for HIV Treatment Recently, Merck & Co Inc (NYSE: MRK) announced promising results from two important Phase 3 clinical trials. This involved their investigational two-drug regimen combining doravirine and islatravir (DOR/ISL) aimed at treating adults living with HIV-1 infection. Key Findings from the Trials The trials were designed...

Immunic Achieves Patent Allowance for Vidofludimus Calcium Immunic, Inc. (Nasdaq: IMUX), a leading biotechnology firm, has recently marked a significant milestone by receiving a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for its patent application focused on the use of vidofludimus calcium, particularly in the treatment of progressive...

Creatd, Inc. Takes a Significant Step with OTCQB Approval Creatd, Inc. (OTC: CRTD) has reached a significant milestone by being approved to trade on the OTCQB Venture Market. This remarkable achievement showcases the company's dedication and progress towards enhancing its market presence. Starting from a pivotal date, Creatd will now be traded on a more recognized...

KROMATID Launches KROMASURE PinPoint for Enhanced Genomic Analysis With an aim to transform gene therapy development, KROMATID has unveiled its innovative KROMASURE PinPoint system. This next-generation platform revolutionizes transgene integration analysis by providing single-cell resolution that was previously unattainable. Researchers now have the ability to detect...